Literature DB >> 28736824

Evaluation of lumazine synthase from Bacillus anthracis as a presentation platform for polyvalent antigen display.

Yangjie Wei1,2, Newton Wahome1,2, Greta VanSlyke3, Neal Whitaker1,2, Prashant Kumar1,3, Michael L Barta2, Wendy L Picking2, David B Volkin1,2, Nicholas J Mantis3, C Russell Middaugh1,2.   

Abstract

Polyvalent antigen display is an effective strategy to enhance the immunogenicity of subunit vaccines by clustering them in an array-like manner on a scaffold system. This strategy results in a higher local density of antigens, increased high avidity interactions with B cells and other antigen presenting cells, and therefore a more effective presentation of vaccine antigens. In this study, we used lumazine synthase (LS), an icosahedral symmetry capsid derived from Bacillus anthracis, as a scaffold to present 60 copies of a linear B cell epitope (PB10) from the ricin toxin fused to the C terminus of LS via four different linkers. We then investigated the effects of linker length, linker rigidity and formaldehyde crosslinking on the protein assembly, conformational integrity, thermal stability, in vitro antibody binding, and immunogenicity in mice. Fusion of the PB10 peptide onto LS, with varying linker lengths, did not affect protein assembly, thermal stability or exposure of the epitope, but had a minor impact on protein conformation. Formaldehyde crosslinking considerably improved protein thermal stability with only minor impact on protein conformation. All LS_PB10 constructs, when administered to mice by injection without adjuvant, elicited measurable anti-ricin serum IgG titers, although the titers were not sufficient to confer protection against a 10× lethal dose ricin challenge. This work sheds light on the biophysical properties, immunogenicity and potential feasibility of LS from B. anthracis as a scaffold system for polyvalent antigen display.
© 2017 The Protein Society.

Entities:  

Keywords:  immunogenicity; lumazine synthase; polyvalent antigen display; ricin; stability; vaccine

Mesh:

Substances:

Year:  2017        PMID: 28736824      PMCID: PMC5606532          DOI: 10.1002/pro.3243

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  29 in total

1.  Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.

Authors:  Yuan Lu; Wei Chan; Benjamin Y Ko; Christopher C VanLang; James R Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

2.  Crystallographic refinement of ricin to 2.5 A.

Authors:  E Rutenber; B J Katzin; S Ernst; E J Collins; D Mlsna; M P Ready; J D Robertus
Journal:  Proteins       Date:  1991

Review 3.  Nanoparticle vaccines.

Authors:  Liang Zhao; Arjun Seth; Nani Wibowo; Chun-Xia Zhao; Neena Mitter; Chengzhong Yu; Anton P J Middelberg
Journal:  Vaccine       Date:  2013-12-02       Impact factor: 3.641

4.  Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy.

Authors:  András Micsonai; Frank Wien; Linda Kernya; Young-Ho Lee; Yuji Goto; Matthieu Réfrégiers; József Kardos
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-02       Impact factor: 11.205

5.  Production of Well-Characterized Virus-like Particles in an Escherichia coli-Based Expression Platform for Preclinical Vaccine Assessments.

Authors:  Newton Wahome; Anne Cooper; Prem Thapa; Shyamal Choudhari; Fei P Gao; David B Volkin; C Russell Middaugh
Journal:  Methods Mol Biol       Date:  2016

6.  Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles.

Authors:  Lei Hu; Jared M Trefethen; Yuhong Zeng; Luisa Yee; Satoshi Ohtake; David Lechuga-Ballesteros; Kelly L Warfield; M Javad Aman; Sergey Shulenin; Robert Unfer; Sven G Enterlein; Vu Truong-Le; David B Volkin; Sangeeta B Joshi; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2011-08-19       Impact factor: 3.534

7.  Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1.

Authors:  Cordula Klockenbusch; Juergen Kast
Journal:  J Biomed Biotechnol       Date:  2010-06-28

8.  Identification of formaldehyde-induced modifications in proteins: reactions with model peptides.

Authors:  Bernard Metz; Gideon F A Kersten; Peter Hoogerhout; Humphrey F Brugghe; Hans A M Timmermans; Ad de Jong; Hugo Meiring; Jan ten Hove; Wim E Hennink; Daan J A Crommelin; Wim Jiskoot
Journal:  J Biol Chem       Date:  2003-11-24       Impact factor: 5.157

9.  Tomato bushy stunt virus (TBSV), a versatile platform for polyvalent display of antigenic epitopes and vaccine design.

Authors:  Shantanu Kumar; Wendy Ochoa; Pratik Singh; Catherine Hsu; Anette Schneemann; Marianne Manchester; Mark Olson; Vijay Reddy
Journal:  Virology       Date:  2009-04-02       Impact factor: 3.616

10.  Design and characterization of structured protein linkers with differing flexibilities.

Authors:  Joshua S Klein; Siduo Jiang; Rachel P Galimidi; Jennifer R Keeffe; Pamela J Bjorkman
Journal:  Protein Eng Des Sel       Date:  2014-10       Impact factor: 1.650

View more
  1 in total

Review 1.  Second career of a biosynthetic enzyme: Lumazine synthase as a virus-like nanoparticle in vaccine development.

Authors:  Rudolf Ladenstein; Ekaterina Morgunova
Journal:  Biotechnol Rep (Amst)       Date:  2020-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.